Investigation of the solution-phase structure of macrocyclic anti-leukemia drug midostaurin

Abstract

This study presents the solution structure of the macrocyclic anti-leukemia agent midostaurin, based on the excellent agreement between the experimental electronic circular dichroism (ECD) spectrum in solution and the theoretical spectra of the midostaurin-solvent aggregate. This approach establishes a straightforward and effective methodology for structural characterization in solution.

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Communication
Submitted
12 Dec 2025
Accepted
03 Apr 2026
First published
06 Apr 2026

Phys. Chem. Chem. Phys., 2026, Accepted Manuscript

Investigation of the solution-phase structure of macrocyclic anti-leukemia drug midostaurin

Z. jiang, Q. Wang, H. Xu, Y. lv, Y. lei, Y. Jin, Y. sun and Z. Wang, Phys. Chem. Chem. Phys., 2026, Accepted Manuscript , DOI: 10.1039/D5CP04820F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements